North America is witnessing growing demand for anterior uveitis treatment due to advanced healthcare infrastructure, greater access to specialized ophthalmic services, and increasing awareness of inflammatory eye conditions. The region benefits from the presence of established pharmaceutical and biotechnology companies, strong clinical research capabilities, and ongoing innovation in ophthalmic...